PubMed Health⌕ Search
Home/Archive/PubMed

PubMed · 7756921

[Diabetic nephropathy].

D Garceau·M Turgeon·S Gagnon
View original source ↗Export metadata ↓

Abstract

Diabetic nephropathy morbidity and mortality rates are high for both Type I and Type II diabetes. The various stages of diabetic nephropathy have been well documented for Type I diabetes, but not for Type II. We examine the natural history of this problem and recommended treatments, with emphasis on the characteristics of each type.

Explore related subjects

Diabetes Mellitus, Type 1Diabetes Mellitus, Type 2Diabetic NephropathiesHumansEnglish AbstractJournal ArticleReview

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

D Garceau, M Turgeon, S Gagnon. 1995. [Diabetic nephropathy].. https://pubmed.ncbi.nlm.nih.gov/7756921/

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

PubMed1997

Insulin analogues.

Explore the source record for details and available documents.

Diabetes Mellitus, Type 1↗
PubMed1996

Diabetes research: are we getting anywhere?

Although 75 years have elapsed since the discovery of insulin, diabetes mellitus continues to be a chronic disease associated with significant morbidity and mortality. However, progress in basic and clinical research has advanced our understanding of the pathophysiology of the disease. The development of animal models has facilitated research into the autoimmune processes that underlie insulin-dependent diabetes, although the factors that trigger these mechanisms still remain a mystery. Research into non-insulin-dependent diabetes has furthered our understanding of the action of insulin at the molecular and cellular level and raised questions about the genetic basis of the disease. In addition, concerted efforts are being made to improve insulin therapy and develop interventions to prevent or mitigate the complications of diabetes. Researchers are now on the threshold of testing new therapies that one day may change the long-term outcome for people with diabetes.

Diabetes Mellitus, Type 1↗